These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 703469)
21. Some observations on research methodologies used in drug product selection studies. Pathak DS; Simon LS Drug Intell Clin Pharm; 1980 Feb; 14(2):126-33. PubMed ID: 10246118 [No Abstract] [Full Text] [Related]
22. HEW promotes wider use of generic drugs, predicts savings under reimbursement plan. Hospitals; 1979 Feb; 53(3):17. PubMed ID: 759296 [No Abstract] [Full Text] [Related]
23. Substitution: expectations and realization. Gorrell JM Med Mark Media; 1981 May; 16(5):52, 54-7. PubMed ID: 10251529 [No Abstract] [Full Text] [Related]
24. How many patients still get the drug you prescribe? Rosenberg CL Med Econ; 1979 Sep; 56(18):35-6, 40, 44 passim. PubMed ID: 10243615 [No Abstract] [Full Text] [Related]
25. FDA drug list: key to generic substitution. FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816 [TBL] [Abstract][Full Text] [Related]
26. Generic drugs provide no big savings so far in nation's health bill. Lublin JS; Jaroslovsky R Wall St J Midwest Ed; 1978 Dec; 59(38):1, 19. PubMed ID: 10239001 [No Abstract] [Full Text] [Related]
27. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation. Segal R; Grines LL; Pathak DS Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459 [TBL] [Abstract][Full Text] [Related]
28. Benefits and liabilities of generic prescribing. Lee AM W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384 [No Abstract] [Full Text] [Related]
29. States moving to allow generic substitution. Internist; 1979 May; 20(4):12-3. PubMed ID: 10242129 [No Abstract] [Full Text] [Related]
30. The high price of mandatory substitution. Dickinson J Hosp Formul; 1978 Oct; 13(10):811-2. PubMed ID: 10238813 [No Abstract] [Full Text] [Related]
31. The case for use of generic names. Pepper GA Nurse Pract; 1985 Aug; 10(8):43, 47. PubMed ID: 4047529 [No Abstract] [Full Text] [Related]
32. 25th annual prescription survey: Albany College of Pharmacy of Union University. DeNuzzo RV Med Mark Media; 1981 Apr; 16(4):31-2, 34-51. PubMed ID: 10250762 [No Abstract] [Full Text] [Related]
33. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle. Felch WC Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131 [No Abstract] [Full Text] [Related]
34. Economic issues in the antisubstitution controversy. Sharpe TR Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879 [No Abstract] [Full Text] [Related]
35. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
36. A political economy perspective: why pharmacists may be reluctant to dispense generic medications. Pelton LE; Strutton D; Smith MC J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135 [TBL] [Abstract][Full Text] [Related]
37. FTC: our model product selection law relies on the pharmacist's expertise. Holmes PD Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271 [No Abstract] [Full Text] [Related]
38. Physicians' attitudes toward and knowledge about generic drug substitution. Friedman D; Jaffe A; Steinhardt S N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720 [No Abstract] [Full Text] [Related]
39. Therapeutic substitution--usurpation of the physician's prerogative. Ballin JC JAMA; 1987 Jan 23-30; 257(4):528-9. PubMed ID: 3795436 [No Abstract] [Full Text] [Related]
40. Drug product selection legislation: a comparative analysis. Wetherbee H; Sharpe TR Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]